Items related to Analyzing T Cell Responses: How to analyze cellular...

Analyzing T Cell Responses: How to analyze cellular immune responses against tumor associated antigens - Softcover

 
9789048169115: Analyzing T Cell Responses: How to analyze cellular immune responses against tumor associated antigens

Synopsis

Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN-? ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN-?. Additionally, CTL with lytic activity do not always secrete IFN-? (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell.

"synopsis" may belong to another edition of this title.

Review

From the reviews of the first edition:

"This book represents the first comprehensive description, and evaluation of the most important assays utilized to monitor immune responses against tumor associated antigens. ... Specifically tailored to the needs of clinical researchers, basic science investigators, and biotechnology innovators, this book provides information that is both sufficiently detailed and eloquently succinct. All discussions are substantiated with a comprehensive literature review. ... Analyzing T Cell Responses provides the most substantial and extensive review of immune response-monitoring techniques available to date." (Melanie Hayden, Stephanie Schroter and Boris Minev, Angiogenesis, Vol. 9, 2006)

"About this title" may belong to another edition of this title.

Other Popular Editions of the Same Title

9781402036224: Analyzing T Cell Responses: How to analyze cellular immune responses against tumor associated antigens

Featured Edition

ISBN 10:  1402036221 ISBN 13:  9781402036224
Publisher: Springer, 2005
Hardcover

Search results for Analyzing T Cell Responses: How to analyze cellular...

Stock Image

Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Softcover

Seller: Lucky's Textbooks, Dallas, TX, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # ABLIING23Apr0316110338153

Contact seller

Buy New

£ 138.49
Convert currency
Shipping: £ 3.01
Within U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Stock Image

Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Softcover

Seller: Ria Christie Collections, Uxbridge, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. In. Seller Inventory # ria9789048169115_new

Contact seller

Buy New

£ 134.13
Convert currency
Shipping: £ 11.98
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Seller Image

Francesco M. Marincola
Published by Springer Netherlands Okt 2010, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Taschenbuch
Print on Demand

Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN- ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN- . Additionally, CTL with lytic activity do not always secrete IFN- (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell. 328 pp. Englisch. Seller Inventory # 9789048169115

Contact seller

Buy New

£ 145.12
Convert currency
Shipping: £ 20.19
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Stock Image

Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Softcover

Seller: California Books, Miami, FL, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # I-9789048169115

Contact seller

Buy New

£ 170.67
Convert currency
Shipping: FREE
Within U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Stock Image

Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Softcover

Seller: Books Puddle, New York, NY, U.S.A.

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

Condition: New. pp. 328. Seller Inventory # 262171990

Contact seller

Buy New

£ 170.85
Convert currency
Shipping: £ 3.01
Within U.S.A.
Destination, rates & speeds

Quantity: 4 available

Add to basket

Stock Image

Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Softcover
Print on Demand

Seller: Majestic Books, Hounslow, United Kingdom

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

Condition: New. Print on Demand pp. 328 49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam. Seller Inventory # 5675913

Contact seller

Buy New

£ 180.73
Convert currency
Shipping: £ 6.50
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: 4 available

Add to basket

Stock Image

Nagorsen Dirk Marincola Francesco M.
Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Softcover
Print on Demand

Seller: Biblios, Frankfurt am main, HESSE, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. PRINT ON DEMAND pp. 328. Seller Inventory # 182171996

Contact seller

Buy New

£ 188.63
Convert currency
Shipping: £ 8.74
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 4 available

Add to basket

Seller Image

Francesco M. Marincola
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Taschenbuch
Print on Demand

Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN- ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN- . Additionally, CTL with lytic activity do not always secrete IFN- (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 328 pp. Englisch. Seller Inventory # 9789048169115

Contact seller

Buy New

£ 145.12
Convert currency
Shipping: £ 52.67
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket

Seller Image

Francesco M. Marincola
Published by Springer Netherlands, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Taschenbuch

Seller: AHA-BUCH GmbH, Einbeck, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN- ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN- . Additionally, CTL with lytic activity do not always secrete IFN- (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell. Seller Inventory # 9789048169115

Contact seller

Buy New

£ 148.74
Convert currency
Shipping: £ 55.13
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket

Stock Image

Nagorsen, Dirk (Editor) / Marincola, Francesco M. (Editor)
Published by Springer, 2010
ISBN 10: 9048169119 ISBN 13: 9789048169115
New Paperback

Seller: Revaluation Books, Exeter, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Paperback. Condition: Brand New. 325 pages. 9.25x6.10x0.77 inches. In Stock. Seller Inventory # x-9048169119

Contact seller

Buy New

£ 197.38
Convert currency
Shipping: £ 12.50
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket